Print Print

Science Chief Replaced At Autism Speaks


Text Size  A  A

A top executive responsible for overseeing the research and scientific efforts of the nation’s largest autism advocacy group is moving on.

Autism Speaks said Thursday that Geraldine Dawson, the group’s chief science officer for the last five years, is leaving. Dawson is being replaced by Robert Ring who has served as vice president of translational research for the organization since 2011.

Dawson is leaving to take a position at Duke University where she will conduct research and do clinical work as a professor of psychiatry and behavioral sciences and serve as director of the university’s autism center. She was Autism Speaks’ first chief science officer.

Records indicate that Autism Speaks’ science portfolio accounts for the largest slice of the nonprofit’s budget at over $24 million in 2011, according to the organization’s tax filing for that year, the most recent that’s publicly available.

As chief science officer, Dawson was the highest paid employee at the nonprofit, earning more than $440,000 in 2011, the tax filing indicates.

In addition to her role at the nonprofit, Dawson also served as a professor of psychiatry at the University of North Carolina at Chapel Hill and she is a member of the Interagency Autism Coordinating Committee, or IACC, a federal autism advisory committee.

Ring initially came to Autism Speaks from Pfizer where he was head of the pharmaceutical giant’s autism research unit.

As of last year, Ring also leads a secondary nonprofit known as DELSIA which was created by Autism Speaks to bring innovations benefiting people with autism to the commercial market.

More in Autism »

Search Jobs

Post a Comment

Disability Scoop welcomes comments, though only a selection are published. In determining which comments will appear beneath a story, we look for submissions that are thoughtful and add new ideas or perspective to the issues addressed within the story. Please keep your remarks brief and refrain from inserting links.

Comments (5 Responses)

  1. MsAmericanPatriot says:

    This is proof positive that Autism Speaks is in bed with the big drug companies since they have them instead of autistics on their board of directors.

  2. Kim Pomares says:

    I hope this means more research. As the co-founder of Mendability, I hope this means more in-depth investigation into Sensory Enrichment therapy for autism.

  3. Whitney says:

    I am not sure it is proof Ms. A Patroit. In the sense I feel this tip of the iceberg scenario where there is a lot more dirt under this charity. While back I remember the research in Brain bank they wanted to do for collecting tissue samples. With DELSIA it seems there is conflict of interest here. I would like to see an actual audit on Ring and all the DELSIA and Autism Speaks.

  4. Autistic says:

    Autism Speaks and science have little to do with each other, despite the huge budget

  5. RA Jensen says:

    Dr. Dawson was replaced by Robert Ring whose background includes working for Big Pharma including Pfizer. Autism Speaks is now the propaganda arm for Big Pharma and is doubling down on experimental drug therapies.

Copyright © 2008-2015 Disability Scoop, LLC. All Rights Reserved. | Privacy Policy | Terms and Conditions | Reprints and Permissions